DeviceTalks Podcast Network

This week’s episode focuses on the entrepreneurs. We open up with an interview with Andy Doraiswamy, founder and CEO of Koya Medical, a company he founded to help find a therapy for his ailing father. Then we revisit with Dr. Todd Brinton, chief scientific officer and corporate vice president at Edwards. This interview initially ran in May 2020 but we’re playing it again to amplify the unusual path that entrepreneurs take to find success.

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone.

Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD.

Subscribe to this podcast on all major podcast apps.

The bioelectronics industry is poised to take off so we visited with Carolina Aguilar, CEO/Co-founder, INBRAIN Neuroelectronics about the field's potential.

Chris Newmarker, executive editor of life sciences at MassDevice, delivers his Newmarker's Newsmakers highlighting news from Dexcom, NeuroMetrix, Nevro, Ancora and the Galien foundation.

Subscribe to this podcast on Google, Amazon, Apple, Spotify and other major podcast channels.

Vicarious Surgical and CMR Surgical recently combined to raise over $1 billion from public and private investors. Big money clearly as found surgical robotics. Now what?

We connect with Per Vegard Nerseth, the new CEO of CMR. Nerseth comes to CMR from the robotics industry, so he brings deep industry understanding of what it will take to get CMR to the next level. The company closed on $600 million for a Series D, which is likely the largest private medtech investment in history.

Later, we reconnect with Adam Sachs, co-founder and CEO of Vicarious

Surgical. Sachs walks us through the process of merging with a SPAC (not for the faint-hearted.) With over $400 million in hand, Vicarious is bringing in senior talent and moving to a legacy filled new HQ to prepare for its next stage.

Chris Newmarker, executive editor of life sciences at MassDevice, brings his Newmarker's Newsmakers highlighting news from Stryker, Heartflow, Hillrom, BardyDx, TransMedics and Imperative Care.

Subscribe to this podcast on every major podcast channel!

This week we’ll focus on investor insights.

First, we’ll talk with Danielle Antalffy, managing director at SVB Leerink. Antalffy covers most of the major medtechs but we’ll focus on a new report she issues on sugaring home-based dialysis business.

What does this mean for Outset specifically? More broadly, do other medtechs need to build out their at-home/connectivity function?

Also, what does NeuroPace’s success mean for other medtech companies.

In a follow up to our interview with Dr. James Min, CEO of Cleerly Health, we talk with two venture investors in the early heart attack risk detection company.

Justin Klein, MD, of Vensana Capital walks us through the steps he took before leading the company’s recent $43 million Series B round.

Tripp Peake of LRV Health explains why the company interests his venture firm’s limited partner base.

This is an opportunity for entrepreneurs to better understand the venture capital due diligence process.

Chris Newmarker, executive editor of life sciences, delivers his Newmarker’s Newsmakers brings top news from Conformis, Stryker, Siemens Healthineers, Abbott, Medtronic and Levita Magnetics.

LIKE! FOLLOW! SUBSCRIBE! We’re on most major podcast channels.

In this week's DeviceTalks Weekly Podcast, Minnetronix CEO Jeremy Maniak explains how the CMO is using internal know how to develop medical devices that can be sold by outside partners. We also hear from Dr. James Min of Cleerly Health about that company's start and the process that went into raising $43 million.

Chris Newmarker, executive editor of life sciences at MassDevice, is back to deliver his NewmarkersNewsmakers including news from Costa Rica, Vicarious Surgical, Ethicon, Medtronic and ResMed.

Subscribe to this podcast today on all major podcast channels.

Nicole J. Walker, managing partner, Arboretum Ventures, tells a unique medtech story that begins with her sick grandfather and follows up with her refusal to remove her foot from the door at Advanced Cardiovascular Systems. She says she learned early on that she may not always have all the answers when making a decision but she would have the instincts and mettle to push through. This combination moved through jobs at Guidant, Abbott, Baird and now Arboretum Ventures where she sees an enormous opportunity finding medical device companies.

A year ago, Geoff Martha took over as CEO of medtech's large single company. With the sector in lockdown, the company still undertook a massive reorganization and moved to adopt a new "Medtronic Mindset" that would favor the bold.

In this interview, Martha reviews Year 1, sharing some positive outcomes and disappointments.

Chris Newmarker, executive editor of life sciences, delivers his Newmarkers Newsmakers featuring items from Abbott, Amazon, CVRx, Medtronic, and migraines.

Subscribe on all major podcast platforms - Apple, Google, Amazon, Spotify.

In this week’s podcast, Chris Newmarker, executive editor of life sciences, speaks with Laura Rector, Smith + Nephew’s vice president of ambulatory surgery centers and digital health, about the company’s ARIA care management platform.

The system uses 3D imaging, artificial intelligence and other tools to help patients recover more quickly from large joint replacement surgery. What’s next for the ortho leader?

Meanwhile, Kaila Krum, managing director of Truist Securities, delivers insights on two major stories of the week – the decision by Mike Coyle to leave the CEO post at iRhythm and Medtronic’s decision to pull its Heartware HVAD off the shelves.

Those two stories topped this week’s Newmarker’s Newsmakers, which also include items featuring Abbott, Abiomed and the FDA.

Subscribe on Google, Amazon, Apple, Spotify, and other leading podcast channels.

This week we’ll explore innovation and social equity.

First, we’ll hear a portion of an interview with Martha Ha, chief privacy officer and chief counsel of corporate governance, and Jon de Csepel, CMO, vice president, medical affairs of the Americas. The pair will explain how the company is reaching out to employees of Asia and Pacific Island and helping them to understand how to better work within the corporate culture. The entire interview can be heard in the latest MedtronicTalks Podcast

Josh Makower, MD, is our closing keynote guest. Makower quite possibly invented modern day medtech innovation. In this interview, Makower shares his earliest inventions – kind of mind-blowing – and how his early work at Pfizer helped him create the innovation process used today by biodesign programs across the world, including Stanford Biodesign where Dr. Makower will take over as director this fall. This interview is essential for any individual or organization that wants to innovate.

Chris Newmarker, executive editor of life sciences at MassDevice, returns to the podcast with a Newmarker’s Newsmakers that highlights COVID-19, Rapid Medical, iRhythm, Elizabeth Holmes and Medtronic.

Tom Salemi also has big news!

Subscribe to this podcast on Apple Podcasts, Google, Spotify, Amazon and other major platforms.